Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite

Cardiovascular Research

Volumn 40, Issue 2, 1998, Pages 380-388

  Brown, Angie S ^a   Moro, Maria A ^b   Masse, Jean Marc ^c   Cramer, Elizabeth M ^c   Radomski, Marek ^d   Darley Usmar, Victor ^e  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY OF ALBERTA   (Canada)

^e University of Alabama at Birmingham   (United States)

Author keywords

CGMP; Nitric oxide; P selectin; Peroxynitrite; Platelets

Indexed keywords

CALCIUM ION; COLLAGEN; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; NITRIC OXIDE; OXYHEMOGLOBIN; PADGEM PROTEIN; PEROXYNITRITE; THIOL DERIVATIVE;

ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL PROTECTION; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

BLOOD PLATELETS; CALCIUM; COLLAGEN; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; FREE RADICAL SCAVENGERS; GUANYLATE CYCLASE; HUMANS; IMMUNOHISTOCHEMISTRY; NITRATES; NITRIC OXIDE; OXADIAZOLES; OXIDANTS; OXYHEMOGLOBINS; P-SELECTIN; PLATELET ACTIVATION; QUINOXALINES;

EID: 0032212758     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00182-5     Document Type: Article

References (46)

1. [1] Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
2. [2] Brown GC. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischaemic pathologies. Mol Cell Biochem 1997;174:189-192.
3. [3] Brady AJB, Poole-Wilson PA. Circulatory failure in septic shock. Br Heart J 1993;70:103-105.
4. [4] Brune B, Messmer UK, Sandau K. The role of nitric oxide in cell injury. Toxicol Lett 1995;82-83:233-237.
5. [5] Barbior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978;298:659-668.
6. [6] Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996;13:649-662.
7. [7] Mathies G, Sherman MP, Buckberg GD, et al. Role of L-arginine-nitric oxide dependent pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-H620.
8. [8] Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 1986;329:454-456.
9. [9] Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
10. [10] Patel RP, Diczfalusy U, Dzeletovic S, Wilson MT, Darley-Usmar VM. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J Lipid Res 1996;37:2361-2371.
11. [11] Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250.
12. [12] Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446-451.
13. [13] Kooy NW, Royall JA. Agonist induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 1992;301:352-359.
14. [14] Zhu L, Gunn C, Beckman J. Bacteriocidal activity of peroxynitrite. Arch Biochem Biophys 1992;298:452-457.
15. [15] Beckman JS. Ischaemic injury mediator. Nature 1990;345:27-28.
16. [16] Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991;88:6368-6371.
17. [17] Mulligan MS, Hevel JM, Marletta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 1991;88:6338-6342.
18. [18] Beckmann JS, Zu Ye Y, Anderson G, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Hoppe-Seyler's Biol Chem 1994;375:81-88.
19. [19] Leeuwenburgh C, Hardy MM, Hazen SL, et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997;272:1433-1436.
20. [20] Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
21. [21] Liu P, Hock CE, Nagele R, Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 1997;272:H2327-H2336.
22. [22] Moro MA, Darley-Usmar VM, Goodwin DA, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994;91:6702-6706.
23. [23] Moro MA, Darley-Usmar VM, Lizasoain I, et al. The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol 1995;116:1999-2004.
24. [24] Yin K, Lai PS, Rodriguez A, Spur BW, Wong PY. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets. Prostaglandins 1995;50:169-178.
25. [25] Mondoro TH, Shafer BC, Vostal JG. Peroxynitrite-induced tyrosine nitration and phosphorylation in human platelets. Free Radic Biol Med 1997;22:1055-1063.
26. [26] Cheung PY, Salas E, Schulz R, Radomski MW. Nitric oxide and platelet function: implications for neonatology. Semin Perinatol 1997;21:409-417.
27. [27] Nossuli TO, Hayward R, Scalia R, Lefer AM. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation 1997;96:2317-2324.
28. [28] Van Der Vliet A, Smith D, O'Neil CA, et al. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 1994;303:295-301.
29. [29] Wu M, Pritchard KA, Kaminski PM, Fayngersh RP, Hintze TH, Wolin MS. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol 1994;266:H2108-H2113.
30. [30] Kooy NW, Lewis SJ. Elevation in arterial blood pressure following the development of tachyphylaxis to peroxynitrite. Eur J Pharmacol 1996;307:R5-R7.
31. [31] White CR, Moellering D, Patel R, et al. Formation of the NO donors glyceryl mononitrate and glyceryl mononitrite from the reaction of peroxynitrite with glycerol. Biochem J 1997;328:517-524.
32. [32] Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 1995;270:17355-17360.
33. [33] Lefer DJ, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997;99:684-691.
34. [34] Radomski MW, Moncada S. An improved method for washing of human platelets with prostacyclin. Thromb Res 1983;30:383-389.
35. [35] Moro MA, Russell RJ, Cellek S, et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanyl cyclase. Proc Natl Acad Sci USA 1996;93:1480-1485.
36. [36] Schrammel A, Behrends S, Schmidt K, Koesling D, Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 1996;50:1-5.
37. [37] Leduc EH, Bernhard W. Recent modification of the glycol methacrylate embedding procedure. J Ultrastruct Res 1967;19:196-199.
38. [38] DeMay J. A critical review of light and electron microscopy immunocytochemical techniques used in neurobiology. J Neurosci Methods 1983;7:1-18.
39. [39] Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
40. [40] Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg Chem 1985;24:3504-3505.
41. [41] White CR, Crow JP, Spear N, et al. Methods in molecular biology: nitric oxide protocols. Making and working with peroxynitrite. Humana Press Inc. 1997;100:215-230.
42. [42] Paterson RA, Eagles PAM, Young DAB, Beddell CR. Rapid preparation of large quantities of human haemoglobin with low phosphate content by counter-flow dialysis. Int J Biochem 1976;7:117-118.
43. [43] Grynkiewicz G, Poenie M, Tsien RY. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
44. [44] Naseem KM, Bruckdorfer KR. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem J 1995;310:149-153.
45. [45] Kim YM, de Vera ME, Watkins S, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997;272:1402-1411.
46. [46] Polte T, Oberle S, Schroder H. Nitric oxide protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible involvement of cyclic GMP. FEBS Lett 1997;409:46-48.